CAS Space and Guangzhou Laboratory co-develop a space pharmaceutical payload, aiming for a suborbital test in Q1 2027
The two will run protein and small-molecule drug crystallisation experiments to validate space pharmaceutical equipment, laying groundwork for routine use of space biomedical hardware.